Burst-suppression pattern on electroencephalography (EEG) occurs upon dissociation of the cortex from underlying brain structures. Unless the pattern is a physiologic consequence of administered sedatives, this electroencephalographic pattern is indicative of a poor neurologic outcome and high mortality. We report a case of a 29-year-old female thought to be brain dead based on initial physical examination and EEG findings of burst-suppression, who was later found to have supratherapeutic serum levels of bupropion. This is the second documented case of burst-suppression pattern on EEG in a patient who overdosed on bupropion. We propose that burst-suppression in the setting of bupropion toxicity may revert with drug clearance.
SteriadeMAmzicaFContrerasD. Cortical and thalamic cellular correlates of electroencephalographic burst-suppression. Electroencephalogr Clin Neurophysiol. 1994;90(1):1–16.
2.
BorgesMABotósHJBastosRFGodoyMFMarchiNS. Emergency EEG: study of survival. Arq Neuropsiquiatr. 2010;68(2):174–178.
3.
SynekVM. Prognostically important EEG coma patterns in diffuse anoxic and traumatic encephalopathies in adults. J Clin Neurophysiol. 1988;5(2):161–174.
4.
BrennerRP. The interpretation of the EEG in stupor and coma. J Clin Neurophysiol. 1988;5(2):161–174.
5.
FeighnerJPMeredithCHSternWCHendricksonGMillerLL. A double-blind study of bupropion and placebo in depression. Am J Psychiatry. 1984;141(4):525–529.
6.
HewettKChrzanowskiWSchmitzM. Eight-week, placebo-controlled, double-blind comparison of antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. J Psychopharmacol. 2009;23(5):531–538.
7.
ClaytonAHCroftHAHorriganJP. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry. 2006;67(5):736–746.
8.
RushAJTrivediMHWisniewskiSR. Buproprion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354(12):1231–1242.
9.
ErfuthAMichaelNStadtlandCAroltV. Bupropion as an add-on strategy in difficult-to-treat bipolar depressive patients. Neuropsychobiology. 2002;(45 suppl 1):33–36.
10.
WilensTESpencerTJBiedermanJ. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2001;158(2):282–288.
11.
HurtRDSachsDPGloverED. A comparison of Sustained-Release Bupropion and placebo for smoking cessation. N Engl J Med. 1997;337(17):1195–1202.
12.
JorenbyDELeischowSJNidesMA. A controlled trial of sustained release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340(9):685–691.
13.
FavaMRushAJ, Thase ME, et al. 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry. 2005;7(3):106–113.
StarrPKlein-SchwartzWSpillerHKernPEkleberrySEKunkelS. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009;27(8):911–915.
16.
MorazinFLumbrosoAHarryP. Cardiogenic shock and status epilepticus after massive bupropion overdose. Clin Toxicol (Phila). 2007;45(7):794–797.
17.
DruteikaDZedPJ. Cardiotoxicity following bupropion overdose. Ann Pharmacother. 2002;36(11):1791–1795.
DavoudianV. Bupropion Overdose Mimicking Brain Death. American College of Physicians Colorado, Chapter Annual Meeting, Colorado Springs, CO, Broadmoor Hotel; 2008.
